<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0406245390
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2006
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        FINALLERG 1MG-1ML ORAL SOLUTION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CETIRIZINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Oral solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        6.6
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Pharma International Co." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Pharma International Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 513]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI ARABIAN DRUG STORE COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Pharma International Co.
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        R06AE07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Finallerg</strong><strong><sup>&reg; </sup></strong>oral solution contains active ingredient: cetirizine. Cetirizine belongs to a group of anti-allergic medicines called antihistamines.</p><p><strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution is used to treat symptoms associated with allergic conditions, such as:</p><p>&bull; Nasal and ocular symptoms of seasonal and perennial allergic rhinitis.</p><p>&bull; Rashes and itching of chronic urticaria (hives).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Don&rsquo;t take Finallerg</strong><strong><sup>&reg;</sup></strong><strong> Oral Solution</strong></p><p>&bull; If you are allergic (hypersensitive) to cetirizine, hydroxyzine or any piperazine derivatives (closely related active ingredients of other medicines), or to any other ingredients of <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution.</p><p>&bull; If you have severe kidney disease<strong> </strong>(severe impairment of kidney function with creatinine clearance below 10ml/min).</p><p>&bull; If you use other anti-allergic medicines.</p><p>&bull;If you think any of these apply to you, don&rsquo;t take<strong> Finallerg</strong><strong><sup>&reg;</sup></strong> oral solution until you have checked with your doctor.</p><p><strong>Take special care with Finallerg</strong><strong><sup>&reg;</sup></strong><strong> Oral Solution</strong></p><p><strong>Talk to your doctor or pharmacist before using Finallerg</strong><strong><sup>&reg;</sup></strong><strong> Oral Solution:</strong></p><p>&bull; If you have kidney problems<strong> </strong>(your doctor may lower your dose of <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution).</p><p>&bull; If you have difficulty passing urine<strong> </strong>or you have conditions that make you more likely to be unable to empty your bladder, such as spinal cord injury or enlarged prostate.</p><p>&bull; If you have epilepsy<strong> </strong>or you are at risk of convulsions (fits).</p><p>&bull; If you are pregnant of breast-feeding.</p><p>Check with your doctor if you think any of these may apply to you.</p><p><strong>Finallerg</strong><strong><sup>&reg;</sup></strong> oral solution is not recommended for infants and children under 2 years.</p><p><strong>While you are taking Finallerg</strong><strong><sup>&reg; </sup></strong><strong>Oral Solution</strong></p><p>&bull; Avoid alcohol while you are taking <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution<strong>.</strong></p><p>&bull; <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution may affect your allergy test<strong> </strong>results. If you are scheduled for allergy testing ask your doctor if you should stop taking <strong>Finallerg</strong><strong><sup>&reg;</sup></strong> oral solution for several days before testing.</p><p>&bull; Contact you doctor if you have high temperature (fever), shivering or chills, as you may require other type of treatment.</p><p><strong>Conditions you need to look out for</strong></p><p><strong>Finallerg</strong><strong><sup>&reg;</sup></strong> oral solution can make some existing conditions worse, or cause severe allergic reactions or urinary retention. Some people may have suicidal thoughts<strong> </strong>when taking <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution.</p><p>You must look out for certain symptoms while you are taking <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution, to reduce the risk of any problems.</p><p><strong>Other medicines and Finallerg</strong><strong><sup>&reg;</sup></strong><strong> Oral Solution</strong></p><p>Tell your doctor or pharmacist if you&rsquo;re taking any other medicines, if you&rsquo;ve taken any recently, or if you start taking new ones. This includes medicines bought without a prescription. Some medicines may affect how <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong><sup> </sup></strong>oral solution works, or make it more likely that you&rsquo;ll have side effects. <strong>Finallerg</strong><strong><sup>&reg;</sup></strong> oral solution can also affect how some other medicines work. These include:</p><p>Medicines acting on the brain, for example other antihistamines<strong> </strong>such as hydroxizine, clemastine.</p><p>Medicines used to treat anxiety<strong> </strong>such as diazepam or sleeping pills<strong> </strong>such as zolpidem (concurrent administration of <strong>Finallerg</strong><strong><sup>&reg;</sup></strong> oral solution with other agents acting on the brain may cause additional reductions in alertness and impairment of performance).</p><p>Tell your doctor or pharmacist if you are taking any of these.</p><p><strong>Food and drink with Finallerg</strong><strong><sup>&reg;</sup></strong><strong> Oral Solution</strong></p><p>Avoid alcohol when you are taking <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution. In sensitive patients, the concurrent administration of <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution and alcohol may cause additional reductions in alertness and impairment of performance.</p><p><strong>Pregnancy and breast-feeding</strong></p><p><strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution is not recommended for use during pregnancy.</p><p>&bull; Tell your doctor if you are pregnant or planning to become pregnant.</p><p>&bull; If you do become pregnant during treatment with <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution, tell your doctor.</p><p>The ingredients in <strong>Finallerg</strong><strong><sup>&reg;</sup></strong> oral solution can pass into breast milk. If you are breast-feeding, you must check with your doctor before you take <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution.</p><p><strong>Driving and using machines</strong></p><p><strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution at the recommended dose is unlikely to affect your ability to drive or use machines. However, some patients being treated with <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution may feel drowsy, tired or weak<strong>.</strong></p><p>Don&rsquo;t drive or use machines unless you are sure you&rsquo;re not affected.</p><p><strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> oral solution contains sorbitol</strong></p><p>Patients with rare hereditary problems of fructose intolerance should not take this medicine.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>How much to take</strong></p><p>Always take <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong><sup> </sup></strong>oral solution exactly as&nbsp;described in this leaflet or as your&nbsp;doctor or pharmacist have told you. Check with your doctor or pharmacist if you are not sure.</p><p>Don&rsquo;t take&nbsp;more than the recommended dose.</p><p>Don&rsquo;t take&nbsp;<strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong><sup> </sup></strong>oral solution for longer than&nbsp;7 days, without advice of your doctor or pharmacist.</p><p>Contact your doctor&nbsp;if your symptoms worsen or do not improve after 3 days.</p><p><strong>Adults and adolescents above 12 years old</strong></p><p>The usual dose of <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution, is 10 mL (10 mg), once a day.</p><p><strong>Children between 6 and 12 years old</strong></p><p>The usual dose of <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution, is 5 mL (5mg), twice a day.</p><p><strong>Children between 2 and 6 years old</strong></p><p>The usual dose of <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution, is 2.5 mL (2.5mg), twice a day.</p><p><strong>Patients with kidney and liver disease</strong></p><p>Your doctor will decide on the correct dose of <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution depending on the illness and the results of blood tests carried out before treatment. Patients who have end stage impairment of kidney function must not take <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution<strong>.</strong></p><p>If your child suffers from kidney disease, please contact your doctor or pharmacist who may adjust the dose accordingly.</p><p><strong>How to take</strong></p><p>Always take <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong><sup> </sup></strong>oral solution exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. The dose has been prescribed will depend on the treatment plan.</p><p>The solution can be swallowed as such.</p><p><strong>If you forget to take Finallerg</strong><strong><sup>&reg;</sup></strong><strong> Oral Solution</strong></p><p>Don&rsquo;t take an extra dose to make up for a missed dose. Just take your next dose at the usual time.</p><p>If you are not sure what to do, ask your doctor or pharmacist.</p><p><strong>If you take too much Finallerg</strong><strong><sup>&reg;</sup></strong><strong> Oral Solution</strong></p><p>If you take too much <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution, contact your doctor or pharmacist for advice<strong>. </strong>If possible, show them the <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution pack.</p><p>If you take too much <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution you may be more likely to have side effects such as:<strong> </strong>confusion, diarrhoea, dizziness, tiredness, headache, malaise,<strong> </strong>dilating of pupil, itching, restlessness, sedation, somnolence (feeling<strong> </strong>drowsy), stupor, abnormal rapid heart rate, tremor, urinary retention.</p><p><strong>If you stop taking Finallerg</strong><strong><sup>&reg;</sup></strong><strong> Oral Solution</strong></p><p>Rarely, pruritus (intense itching) and/or urticaria may occur if you stop taking <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, <strong>Finallerg</strong><strong><sup>&reg;</sup></strong><strong> </strong>oral solution can cause side effects, but not everybody gets them.</p><p><strong>Conditions you need to look out for:</strong></p><p>Severe allergic reactions<strong>. </strong>Signs include:</p><p>Raised and itchy rash (hives)</p><p>Swelling, sometimes of the face or mouth (angioedema), causing difficulty in swallowing or breathing.</p><p>Collapse or loss of consciousness.</p><p>Urinary retention<strong>. </strong>Signs include:</p><p>Pain when passing urine or inability to pass urine.</p><p>Suicidal thoughts<strong>. </strong>Some people had suicidal thoughts when taking Cetirizine dihydrochloride.</p><p><strong>Contact a doctor immediately if you get these symptoms. Stop taking Finallerg</strong><strong><sup>&reg;</sup></strong><strong> Oral Solution.</strong></p><p><strong>Common side effects (These may affect up to 1 in 10 people):</strong></p><p>&bull; Somnolence (sleepiness).</p><p>&bull; Dizziness, headache.</p><p>&bull; Pharyngitis, rhinitis (in children).</p><p>&bull; Diarrhoea (in children), nausea, dry mouth.</p><p>&bull; Fatigue.</p><p><strong>Uncommon side effects (These may affect up to 1 in 100 people):</strong></p><p>&bull; Agitation.</p><p>&bull; Paraesthesia (tingling or numbness of the hands or feet).</p><p>&bull; Diarrhoea.</p><p>&bull; Stomach pain.</p><p>&bull; Pruritus (itching), rash.</p><p>&bull; Asthenia (unusual weakness), malaise.</p><p><strong>Rare side effects (These may affect up to 1 in 1,000 people):</strong></p><p>&bull; Hypersensitivity.</p><p>&bull; Aggression, confusion, depression, hallucination, insomnia (sleeplessness).</p><p>&bull; Convulsions.</p><p>&bull; Tachycardia (fast heart beat).</p><p>&bull; Abnormal liver function (reflected in the blood tests).</p><p>&bull; Urticaria.</p><p>&bull; Oedema (swelling).</p><p><strong>Very rare side effects (These may affect up to 1 in 10,000 people):</strong></p><p>&bull; Thrombocytopenia (low blood platelets count).</p><p>&bull; Anaphylactic shock.&nbsp;</p><p>&bull; Tics (uncontrolled body movement)</p><p>&bull; Dysgeusia (taste disturbance or loss of taste), dyskinesia (uncontrollable movements), dystonia (uncontrolled muscle spasm), syncope (fainting), tremor.</p><p>&bull; Accommodation disorder (difficulty focusing), blurred vision, oculogyration (eyes having uncontrolled circular movements).</p><p>&bull; Angioedema (serious allergic reaction which causes swelling of the face or throat), fixed drug eruption.</p><p>&bull; Dysuria (pain when passing urine), enuresis (bed wetting).</p><p><strong>Other side effects (Have occurred but their exact frequency is unknown):</strong></p><p>&bull; Increased appetite.</p><p>&bull; Suicidal thoughts.</p><p>&bull; Amnesia, memory impairment.</p><p>&bull; Vertigo (spinning sensation).</p><p>&bull; Urinary retention (difficulty passing urine).</p><p><strong>Tell your doctor or pharmacist if any of the side effects listed becomes severe or troublesome, or if you notice any side effects not listed in this leaflet.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>Do not use <strong>Finallerg</strong><strong><sup>&reg;</sup></strong> oral solution after the expiry date (EXP) which is stated on the blister, label and the carton.</p><p>The expiry date refers to the last day of that month.</p><p><strong>Finallerg</strong><sup>&reg; </sup>Oral Solution: Store below 30 <sup>o</sup>C, don&rsquo;t refrigerate.</p><p>After opening, the solution should be used within 20 days.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is cetirizine dihydrochloride.</p><p>The other ingredients are sorbitol powder, glycerin, propylene glycol, sodium saccharin (fine powder), methyl paraben, banana liquid flavor, trisodium citrate 2H2O.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Finallerg® oral solution: is a clear colorless solution with characteristic banana odor, presented in amber glass bottles type III, 100 ml, with white polypropylene child resistant screw cap with low density polyethylene transparent plug and white sealing ring embossed drawing on top explaining how to open the cap, intended for oral use. 
Pack size: 100 ml.

To report any side effect(s): 
•Saudi Arabia: 
The National Pharmacovigilance Center (NPC): 
SFDA Call Center: 19999 
E-mail: npc.drug@sfda.gov.sa 
Website: https://ade.sfda.gov.sa
•United Arab of Emirates: 
Pharmacovigilance and Medical Device Section 
P.O. Box: 1853, Tel: 80011111 
Email: pv@mohap.gov.ae 
Drug Department, Ministry of Health & Prevention 
Dubai-UAE. 
•Other GCC States: 
Please contact the relevant competent authority.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharma International Company</p><p>Amman - Jordan</p><p>Tel: 00962-6-5158890 / 5157893</p><p>Fax: 00962-6-5154753</p><p>Email: marketing@pic-jo.com&nbsp;&nbsp;&nbsp;</p><p>&nbsp;</p><p>This leaflet does not contain all the information about your medicine. If you have any questions or are not sure about anything, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 11/2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم على المادة الفعالة: سيتيريزين. ينتمي سيتيريزين إلى مجموعة من الأدوية المضادة للحساسية تعرف بمضادات الهيستامين.</p><p dir="RTL">يستعمل <strong>فيناليرج</strong><strong><sup>&reg;</sup></strong> شراب عن طريق الفم<strong><sup> </sup></strong>لعلاج الأعراض المرتبطة بأمراض الحساسية، مثل:</p><p dir="RTL">أعراض التهاب الأنف التحسسي الموسمي والحولي التي تصيب الأنف و العين.</p><p dir="RTL">طفح وحكة الشرى المزمن.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب</strong><strong> </strong><strong>عدم</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>فيناليرج</strong><strong><sup>&reg; </sup></strong><strong>شراب</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>طريق</strong><strong> </strong><strong>الفم</strong><strong> </strong><strong>في</strong><strong> </strong><strong>الحالات</strong><strong> </strong><strong>التالية</strong><strong>:</strong></p><p dir="RTL">إذا كنت تعاني من التحسس (فرط الحساسية) لسيتيريزين، الهيدروكسيزين، أيّ من مشتقات البيبرازين (المواد الفعالة للأدوية الأخرى وثيقة الصلة)، أو أيّ من المكونات الأخرى في <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم.</p><p dir="RTL">إذا كنت تعاني من مرض حاد في الكلى (قصور حاد في وظائف الكلى مع انخفاض معدل تصفية الكرياتينين عن 10 مل/دقيقة).</p><p dir="RTL">إذا كنت تستعمل أدوية أخرى مضادة للحساسية.</p><p dir="RTL">إذا كنت تعتقد أن أيّ مما سبق ينطبق عليك، لا تتناول <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم إلى أن تتأكد من طبيبك.</p><p dir="RTL"><strong>الاحتياطات</strong><strong> </strong><strong>الخاصة</strong><strong> </strong><strong>عند</strong><strong> </strong><strong>استعمال</strong><strong> </strong><strong>فيناليرج</strong><strong><sup>&reg;</sup></strong><strong> </strong><strong>شراب</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>طريق</strong><strong> </strong><strong>الفم</strong></p><p dir="RTL"><strong>تحدث</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong> </strong><strong>قبل</strong><strong> </strong><strong>استعمال</strong><strong> </strong><strong>فيناليرج</strong><strong><sup>&reg;</sup></strong><strong> </strong><strong>شراب</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>طريق</strong><strong> </strong><strong>الفم</strong><strong>:</strong></p><p dir="RTL">إذا كنت تعاني من مشاكل في الكلى (قد يقلل طبيبك جرعتك من <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم).</p><p dir="RTL">إذا كنت تعاني من صعوبة في التبول أو كنت تعاني من حالات تجعلك أكثر عرضة لعدم القدرة</p><p dir="RTL">على إفراغ المثانة، مثل إصابة النخاع الشوكي أو تضخم البروستات.</p><p dir="RTL">إذا كنت تعاني من الصرع أو كنت عرضة لخطر التشنجات (نوبات ظهور أعراض مفاجئة).</p><p dir="RTL">إذا كنت حامل أو مرضعة.</p><p dir="RTL">تأكد من طبيبك إذا كنت تعتقد أن أي مما سبق قد ينطبق عليك.</p><p dir="RTL">لا يوصى باستعمال <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم للرضع والأطفال الذين يبلغون أقل من عامين.</p><p dir="RTL"><strong>أثناء</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>فيناليرج</strong><strong><sup>&reg;</sup></strong><strong> </strong><strong>شراب</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>طريق</strong><strong> </strong><strong>الفم</strong></p><p dir="RTL">تجنب تناول الكحول أثناء تناول <strong>فيناليرج</strong><strong><sup>&reg;</sup></strong> شراب عن طريق الفم.</p><p dir="RTL">قد يؤثر <strong>فيناليرج</strong><strong><sup>&reg;</sup></strong> شراب عن طريق الفم على نتائج فحص الحساسية لديك. إذا كان من المقرر خضوعك لفحص التحسس، اسأل طبيبك إذا كان يجب عليك التوقف عن تناول <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم لعدة أيام قبل الفحص.</p><p dir="RTL">تحدث مع طبيبك إذا كنت تعاني من ارتفاع درجة الحرارة (حمى)، ارتعاش أو القشعريرة، وذلك لانك قد تحتاج إلى نوع أخر من العلاج.</p><p dir="RTL"><strong>حالات</strong><strong> </strong><strong>ينبغي</strong><strong> </strong><strong>الإنتباه</strong><strong> </strong><strong>لها</strong></p><p dir="RTL">قد يجعل <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم بعض الحالات الحالية أكثر سوءا، أو يسبب تفاعلات التحسس الحادة أو احتباس البول. قد يعاني بعض الأشخاص من أفكار انتحارية عند تناول <strong>فيناليرج</strong><strong><sup>&reg;</sup></strong> شراب عن طريق الفم.</p><p dir="RTL">يجب عليك الإنتباه إلى أعراض معينة أثناء تناول <strong>فيناليرج</strong><strong><sup>&reg;</sup></strong> شراب عن طريق الفم ، وذلك لتقليل خطر حدوث أي مشاكل.</p><p dir="RTL"><strong>الأدوية</strong><strong> </strong><strong>الأخرى</strong><strong> </strong><strong>و</strong><strong> </strong><strong>فيناليرج</strong><strong><sup>&reg;</sup></strong> <strong>شراب</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>طريق</strong><strong> </strong><strong>الفم</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أي أدوية أخرى، أو إذا تناولت أي أدوية مؤخرا، أو إذا بدأت في تناول أدوية جديدة. بما في ذلك الأدوية التي يتم الحصول عليها بدون وصفة طبية. قد تؤثر بعض الأدوية على طريقة عمل <strong>فيناليرج</strong><strong><sup>&reg;</sup></strong><strong> </strong>شراب عن طريق الفم، أو تزيد من احتمال تعرضك لآثار جانبية. يمكن أن يؤثر <strong>فيناليرج</strong><strong><sup>&reg;</sup></strong><strong> </strong>شراب عن طريق الفم<strong><sup> </sup></strong>أيضا على طريقة عمل بعض الأدوية الأخرى. تتضمن هذه الأدوية ما يلي:</p><p dir="RTL">الأدوية التي تعمل على الدماغ، على سبيل المثال مضادات الهيستامين الأخرى مثل الهيدروكسيزين، والكليماستين.</p><p dir="RTL">الأدوية التي تستعمل لعلاج القلق مثل الديازيبام أو العقاقير المنومة مثل الزولبيديم (قد يسبب تناول <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم بالتزامن مع العوامل الأخرى التي تعمل على الدماغ في حدوث انخفاض إضافي في مستوى اليقظة وضعف الأداء).</p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أي من هذه الأدوية.</p><p dir="RTL"><strong>تناول</strong><strong> </strong><strong>الطعام</strong><strong> </strong><strong>والشراب</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>فيناليرج</strong><strong><sup>&reg;</sup></strong> <strong>شراب</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>طريق</strong><strong> </strong><strong>الفم</strong></p><p dir="RTL">تجنب تناول الكحول أثناء تناول <strong>فيناليرج</strong><strong><sup>&reg;</sup></strong> شراب عن طريق الفم. قد يؤدي تناول <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم بالتزامن مع الكحوليات إلى حدوث انخفاض إضافي في مستوى اليقظة وضعف الأداء عند المرضى الذين يعانون من التحسس.</p><p dir="RTL"><strong>الحمل</strong><strong> </strong><strong>والرضاعة</strong><strong> </strong><strong>الطبيعية</strong></p><p dir="RTL">لا يوصى بتناول <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم أثناء الحمل.</p><p dir="RTL">أخبري طبيبك إذا كنت حامل أو تخططين للحامل.</p><p dir="RTL">إذا أصبحت حامل أثناء العلاج باستعمال <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق، أخبري طبيبك.</p><p dir="RTL">قد تفرز مكونات <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم في حليب الثدي. إذا كنت مرضعة، يجب أن تتأكد من طبيبك قبل تناول <strong>فيناليرج</strong><strong><sup>&reg;</sup></strong> شراب عن طريق الفم.</p><p dir="RTL"><strong>القيادة</strong><strong> </strong><strong>واستخدام</strong><strong> </strong><strong>الآلات</strong></p><p dir="RTL">من غير المحتمل أن يؤثر تناول <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم بالجرعة الموصى بها على قدرتك على القيادة أو استخدام الآلات. ومع ذلك، قد يشعر بعض المرضى الذين يتم علاجهم باستعمال <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم بالنعاس، التعب أو الضعف.</p><p dir="RTL">تجنب القيادة و استخدام الآلات ما لم تكن متاكدا بأنك لا تتاثر.</p><p dir="RTL"><strong>يحتوي</strong><strong> </strong><strong>فيناليرج</strong><strong><sup>&reg; </sup></strong><strong>شراب</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>طريق</strong><strong> </strong><strong>الفم</strong><strong> </strong><strong>على</strong><strong> </strong><strong>مادة</strong><strong> </strong><strong>السوربيتول</strong></p><p dir="RTL">يجب أن لا يتناول هذا الدواء المرضى الذين يعانون من مشاكل وراثية نادرة من عدم تحمل الفركتوز.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الجرعة</strong><strong> </strong></p><p dir="RTL">دائماً تناول <strong>فيناليرج</strong><strong><sup>&reg;</sup></strong><strong> </strong>شراب عن طريق الفم<strong> </strong>تماماً كما هو موصوف في هذه النشرة أو كما اخبرك طبيبك أو الصيدلي. تأكد من طبيبك أو الصيدلي إذا كنت غير متاكد.</p><p dir="RTL">لا تتناول أكثر من الجرعة الموصى بها.</p><p dir="RTL">لا تتناول<strong> </strong><strong>فيناليرج</strong><strong><sup>&reg;</sup></strong><strong> </strong>شراب عن طريق الفم لأكثر من 7 أيام، بدون استشارة طبيبك أو الصيدلي.</p><p dir="RTL">اتصل مع طبيبك إذا ساءت الأعراض أو لم تتحسن حالتك بعد 3 أيام.</p><p dir="RTL"><strong>الكبار</strong><strong> </strong><strong>والمراهقون</strong><strong> </strong><strong>الذين</strong><strong> </strong><strong>يبلغون</strong><strong> </strong><strong>أكثر</strong><strong> </strong><strong>من</strong><strong> 12 </strong><strong>عاما</strong></p><p dir="RTL">الجرعة المعتادة من <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم هي 10 مل (10 ملغم)، مرة واحدة يوميا.</p><p dir="RTL"><strong>الأطفال</strong><strong> </strong><strong>الذين</strong><strong> </strong><strong>يبلغون</strong><strong> </strong><strong>من</strong><strong> 6 </strong><strong>إلى</strong><strong> 12 </strong><strong>عاما</strong></p><p dir="RTL">الجرعة المعتادة من <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم هي 5 مل (5 ملغم)، مرتين يوميا.</p><p dir="RTL"><strong>الأطفال</strong><strong> </strong><strong>الذين</strong><strong> </strong><strong>يبلغون</strong><strong> </strong><strong>من</strong><strong> 2 </strong><strong>إلى</strong><strong> 6 </strong><strong>أعوام</strong></p><p dir="RTL">الجرعة المعتادة من <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم هي 2.5 مل (2.5 ملغم)، مرتين يوميا.</p><p dir="RTL"><strong>المرضى</strong><strong> </strong><strong>الذين</strong><strong> </strong><strong>يعانون</strong><strong> </strong><strong>من</strong><strong> </strong><strong>مرض</strong><strong> </strong><strong>في</strong><strong> </strong><strong>الكلى</strong><strong> </strong><strong>والكبد</strong></p><p dir="RTL">سيقرر طبيبك الجرعة الصحيحة من <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم اعتمادا على المرض ونتائج فحوصات الدم التي تم إجرائها قبل العلاج. يجب على المرضى الذين يعانون من المرحلة النهائية من قصور وظائف الكلى عدم تناول <strong>فيناليرج</strong><strong><sup>&reg;</sup></strong> شراب عن طريق الفم.</p><p dir="RTL">إذا كان طفلك يعاني من مرض في الكلى، يرجى الاتصال مع طبيبك أو الصيدلي من أجل تعديل الجرعة وفقا لذلك.</p><p dir="RTL"><strong>كيفية</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>فيناليرج</strong><strong><sup>&reg; </sup></strong><strong>شراب</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>طريق</strong><strong> </strong><strong>الفم</strong></p><p dir="RTL">دائماً تناول <strong>فيناليرج</strong><strong><sup>&reg;</sup></strong><strong> </strong>شراب عن طريق الفم<strong> </strong>تماماً كما اخبرك طبيبك. تأكد من طبيبك، الصيدلي إذا لم تكن متاكدا. سوف تعتمد الجرعة التي تم وصفها على خطة العلاج.</p><p dir="RTL">يمكن تناول الشراب كما هو.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>نسيت</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>جرعة</strong><strong> </strong><strong>فيناليرج</strong><strong><sup>&reg;</sup></strong><strong> </strong><strong>شراب</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>طريق</strong><strong> </strong><strong>الفم</strong></p><p dir="RTL">لا تتناول جرعة إضافية لتعويض الجرعة التي نسيتها. فقط تناول جرعتك التالية في الوقت المعتاد.</p><p dir="RTL">إذا لم تكن متأكد، اسأل طبيبك أو الصيدلي.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>تناولت</strong><strong> </strong><strong>فيناليرج</strong><strong><sup>&reg;</sup></strong><strong> </strong><strong>شراب</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>طريق</strong><strong> </strong><strong>الفم</strong><strong> </strong><strong>أكثر</strong><strong> </strong><strong>مما</strong><strong> </strong><strong>يجب</strong></p><p dir="RTL">إذا تناولت<strong> </strong><strong>فيناليرج</strong><strong><sup>&reg;</sup></strong><strong> </strong>شراب عن طريق الفم أكثر مما يجب، استشر طبيبك أو الصيدلي.</p><p dir="RTL">أريهم عبوة <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>إذا كان ذلك ممكنًا.</p><p dir="RTL">في حالة تناول أكثر مما يجب من <strong>فيناليرج</strong><strong><sup>&reg;</sup></strong><strong> </strong>شراب عن طريق الفم، قد تكون أكثر عرضة للإصابة بآثار جانبية مثل: ارتباك، إسهال، الشعور بالدوار، تعب، صداع، توعك، اتساع حدقة العين، حكة، الشعور بعدم الراحة، الشعور بالنعاس، سكون، الذهول، معدل نبضات القلب سريع وغير طبيعي، رعاش، احتباس البول.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>توقفت</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>فيناليرج</strong><strong><sup>&reg;</sup></strong><strong> </strong><strong>شراب</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>طريق</strong><strong> </strong><strong>الفم</strong></p><p dir="RTL">قد تعاني في حالات نادرة من الحكة (الحكة الشديدة) و/أو الشرى إذا توقفت عن تناول <strong>فيناليرج</strong><strong><sup>&reg;</sup></strong><strong> </strong>شراب عن طريق الفم.</p><p dir="RTL">إذا كان لديك أية أسئلة إضافية عن استعمال هذا الدواء، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم<strong><sup> </sup></strong>آثار جانبية، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL"><strong>حالات</strong><strong> </strong><strong>ينبغي</strong><strong> </strong><strong>الانتباه</strong><strong> </strong><strong>لها</strong><strong>:</strong></p><p dir="RTL">التفاعلات التحسسية الحادة. العلامات تتضمن:</p><p dir="RTL">&nbsp;طفح جلدي بارز عن سطح الجلد مع الحكة (الشرى).</p><p dir="RTL">&nbsp;تورّم، في بعض الأحيان في الوجه أو الفم (وذمة وعائية)، الذي يسبب صعوبة في البلع أو التنفس.</p><p dir="RTL">&nbsp;وهط أو فقدان الوعي.</p><p dir="RTL">احتباس البول. العلامات تتضمن:</p><p dir="RTL">&nbsp;الشعور بالألم عند التبول أو عدم القدرة على التبول.</p><p dir="RTL">أفكار انتحارية. قد عاني بعض الأشخاص من أفكار انتحارية عند تناول سيتيريزين ثنائي الهيدروكلوريد.</p><p dir="RTL"><strong>اتصل</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>على</strong><strong> </strong><strong>الفور</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>عانيت</strong><strong> </strong><strong>من</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>الأعراض</strong><strong>. </strong><strong>توقف</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>فيناليرج</strong><strong><sup>&reg;</sup></strong> <strong>شراب</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>طريق</strong><strong> </strong><strong>الفم</strong><strong>.</strong></p><p dir="RTL"><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>الشائعة</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> 1 </strong><strong>أو</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 10 </strong><strong>أشخاص</strong><strong>):</strong></p><p dir="RTL">الشعور بالنعاس.</p><p dir="RTL">الشعور بالدوار، صداع.</p><p dir="RTL">التهاب الحلق، التهاب الأنف (عند الأطفال).</p><p dir="RTL">إسهال (عند الأطفال)، الشعور بالغثيان، جفاف الفم.</p><p dir="RTL">الشعور بالتعب.</p><p dir="RTL"><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>الشائعة</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> 1 </strong><strong>أو</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 100 </strong><strong>شخص</strong><strong>):</strong></p><p dir="RTL">تهيج.</p><p dir="RTL">التنميل (الشعور بوخز خفيف في اليدين أو القدمين).</p><p dir="RTL">إسهال.</p><p dir="RTL">ألم في المعدة.</p><p dir="RTL">حكة، طفح.</p><p dir="RTL">الوهن (شعور غير معتاد بالتعب)، توعك.</p><p dir="RTL"><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>النادرة</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> 1 </strong><strong>أو</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 1,000 </strong><strong>شخص</strong><strong>):</strong></p><p dir="RTL">فرط الحساسية.</p><p dir="RTL">عدوانية، ارتباك، اكتئاب، هلوسة، أرق (عدم القدرة على النوم).</p><p dir="RTL">تشنجات.</p><p dir="RTL">زيادة معدل نبضات القلب (نبضات القلب سريعة).</p><p dir="RTL">اضطراب وظائف الكبد (تظهر في اختبارات الدم).</p><p dir="RTL">شرى.</p><p dir="RTL">وذمة (تورم).</p><p dir="RTL"><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>النادرة</strong><strong> </strong><strong>جداً</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> 1 </strong><strong>أو</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 10,000 </strong><strong>شخص</strong><strong>):</strong></p><p dir="RTL">قلة الصفيحات (انخفاض عدد الصفيحات الدموية).</p><p dir="RTL">نوبة تحسس.</p><p dir="RTL">التشنجات اللاإرادية (حركات في الجسم غير مسيطر عليها).</p><p dir="RTL">اضطراب في حاسة التذوق (اضطراب حاسة التذوق أو فقدان القدرة على التذوق)، اضطراب الحركة (حركات لا يمكن السيطرة عليها)، اضطراب التوتر العضلي (تشنج العضلات اللإرادي)، إغماء (فقدان الوعي)، رعاش.</p><p dir="RTL">اضطراب في الاستيعاب (صعوبة في التركيز)، ضبابية الرؤية، حركة المقلة الالتفافية (حركات دائرية لاإرادية بالعين).</p><p dir="RTL">وذمة وعائية (تفاعل تحسسي خطيرة تسبب تورم في الوجه أو الحلق)، الطفح الدوائي الثابت (يظهر في نفس الموقع من الجسم عند تناول دواء معين).</p><p dir="RTL">عسر التبول (الشعور بالألم عند التبول)، وسلس البول (التبول في الفراش).</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>أخرى</strong><strong> (</strong><strong>لقد</strong><strong> </strong><strong>حدثت</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>ا</strong><strong> </strong><strong>الآثار،</strong><strong> </strong><strong>ولكن</strong><strong> </strong><strong>معدل</strong><strong> </strong><strong>تكرارها</strong><strong> </strong><strong>بالضبط</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>معروف</strong><strong>):</strong></p><p dir="RTL">زيادة الشهية.</p><p dir="RTL">أفكار انتحارية.</p><p dir="RTL">&nbsp;فقدان الذاكرة وضعف الذاكرة.</p><p dir="RTL">دوخة (الإحساس بالدوران).</p><p dir="RTL">احتباس البول (صعوبة في التبول).</p><p dir="RTL"><strong>أخبر</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>أصبحت</strong><strong> </strong><strong>أيّ</strong><strong> </strong><strong>من</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>المذكورة</strong><strong> </strong><strong>حادة</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>مزعجة،</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>لاحظت</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>مذكورة</strong><strong> </strong><strong>في</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>النشرة</strong><strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ بعيدا عن متناول الأطفال و نظرهم.</p><p dir="RTL">لا تستعمل <strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم بعد تاريخ انتهاء الصلاحية (EXP) المذكورعلى الملصق و العلبة الخارجية.</p><p dir="RTL">تاريخ الانتهاء يشير إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">يحفظ<strong> </strong><strong>فيناليرج</strong><strong><sup>&reg; </sup></strong>شراب عن طريق الفم في درجة حرارة دون 30&deg;م، لا يوضع في الثلاجة.</p><p dir="RTL">بعد الفتح، يجب استعمال الشراب خلال 20 يوم.</p><p dir="RTL">يجب أن لا يتم التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية.اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة.وسوف تساعد هذه التدابير في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي: سيتيريزين ثنائي الهيدروكلوريد.</p><p dir="RTL">المكونات الأخرى هي مسحوق السوربيتول، جليسيرين، بروبيلين جلايكول، سكارين الصوديوم (مسحوق)، ميثيل بارابين، سائل بنكهة الموز، ستيرات ثنائي مائي ثلاثي الصوديوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>فيناليرج</strong><strong><sup>&reg; </sup></strong><strong>شراب</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>طريق</strong><strong> </strong><strong>الفم</strong>: محلول صافي عديم اللون برائحة الموز، معبأة في زجاجات معتمة نوع III سعة 100 مل، ذات غطاء أبيض قابل للف من البولي بروبيلين مقاوم للفتح من قبل الأطفال مع سدادة شفافة من البولي إيثيلين منخفض الكثافة و حلقة إغلاق بيضاء، محفور بالرسم في الأعلى توضيح كيفية فتح الغطاء، معد للاستعمال عن طريق الفم.</p><p dir="RTL"><strong>حجم</strong><strong> </strong><strong>العبوة</strong><strong>:</strong> 100 مل.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong>:</strong></p><p dir="RTL"><strong>المملكة</strong><strong> </strong><strong>العربية</strong><strong> </strong><strong>السعودية</strong><strong>:</strong></p><p dir="RTL">المركز الوطني للتيقظ الدوائي:</p><p dir="RTL">مركز الاتصال الموحد: 19999</p><p dir="RTL">البريد الالكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">الموقع الالكتروني: https://ade.sfda.gov.sa</p><p dir="RTL"><strong>&bull;</strong><strong>الإمارات</strong><strong> </strong><strong>العربية</strong><strong> </strong><strong>المتحدة</strong><strong>:</strong></p><p dir="RTL">قسم اليقظة الدوائية والأجهزة الطبية</p><p dir="RTL">ص.ب: 1853، هاتف: 80011111</p><p dir="RTL">البريد الإلكتروني: pv@mohap.gov.ae</p><p dir="RTL">قسم الأدوية، وزارة الصحة و وقاية المجتمع</p><p dir="RTL">دبي- الإمارات العربية المتحدة.</p><p dir="RTL"><strong>&bull; </strong><strong>دول</strong><strong> </strong><strong>الخليج</strong><strong> </strong><strong>العربي</strong><strong> </strong><strong>الأخرى</strong><strong>:</strong></p><p dir="RTL">الرجاء الاتصال بالجهات الوطنية في كل دولة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الشركة الدولية للدواء<br />عمان - الأردن<br />الهاتف: 5157893 / 5158890 - 6 - 00962&nbsp;<br />فاكس:&nbsp; 5154753 - 6 - 00962<br />البريد الإلكتروني: marketing@pic-jo.com</p><p dir="RTL">&nbsp;</p><p dir="RTL">هذه النشرة لا تحتوي على جميع المعلومات عن المستحضر. إذا كان لديك أية أسئلة أو لم تكن متأكدا من أي شيء، اسأل طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم تنقيح هذه النشرة في 11/2023


        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Finallerg® 1 mg/ml Oral Solution
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each ml of solution contains 1 mg cetirizine dihydrochloride.

For a full list of excipients: see section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oral solution for oral use.

Finallerg ®oral solution: is a clear colorless solution with banana odor, presented in amber glass bottles type III, 100 ml, with white polypropylene child resistant screw cap with low density polyethylene transparent plug and white sealing ring embossed drawing on top explaining how to open the cap, intended for oral use. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For the relief of</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nasal and ocular symptoms of seasonal and perennial allergic rhinitis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Symptoms of chronic idiopathic urticaria.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Posology</strong></p><p><strong>Adults</strong></p><p>10 mg (20 drops or 10 ml of oral solution or 1 tablet) once daily.</p><p>A 5 mg starting dose (10 drops or 5 ml of oral solution or half of the tablet) may be proposed if this leads to satisfactory control of the symptoms.</p><p><strong>Children</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Children aged from 2 to 6 years</strong></p><p>&nbsp;(2.5 ml of oral solution) twice daily.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Children aged from 6 to 12 years</strong></p><p>&nbsp;(5 ml of oral solution) twice daily.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Children over 12 years of age</strong></p><p>&nbsp;(10 ml of oral solution) once daily.</p><p><strong>Elderly</strong></p><p>Data does not suggest that the dose needs to be reduced in elderly subjects provided that the renal function is normal.</p><p><strong>Renal impairment</strong></p><p>Since cetirizine is mainly excreted via renal route, in cases no alternative treatment can be used, the dosing intervals must be individualised according to renal function.</p><p>Refer to the following table and adjust the dose as indicated.&nbsp; To use this dosing table, an estimate of the patient&rsquo;s creatinine clearance (CLcr) in ml/min is needed.&nbsp; The CLcr&nbsp;(ml/min) may be estimated from serum creatinine (mg/dl) determination using the following formula:</p><p><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="Picture_x0020_1" o:spid="_x0000_i1025" type="#_x0000_t75"
 style='width:281.25pt;height:56.25pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/User/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png"
  o:title="B1B80E59"/>
</v:shape><![endif]--><img width="375" height="75" src="file:///C:/Users/User/AppData/Local/Temp/msohtmlclip1/01/clip_image002.png" /></p><p><strong>Dosing adjustments for adult patients with impaired renal function</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:0px"><tbody><tr><td style="vertical-align:top"><p><strong>Group</strong></p></td><td style="vertical-align:top"><p><strong>Creatinine clearance (ml/min)</strong></p></td><td style="vertical-align:top"><p><strong>Dosage and frequency</strong></p></td></tr><tr><td style="vertical-align:top"><p>Normal</p></td><td style="vertical-align:top"><p>&sup3;80</p></td><td style="vertical-align:top"><p>10 mg once daily</p></td></tr><tr><td style="vertical-align:top"><p>Mild</p></td><td style="vertical-align:top"><p>50 &ndash; 79</p></td><td style="vertical-align:top"><p>10 mg once daily</p></td></tr><tr><td style="vertical-align:top"><p>Moderate</p></td><td style="vertical-align:top"><p>30 &ndash; 49</p></td><td style="vertical-align:top"><p>5 mg once daily</p></td></tr><tr><td style="vertical-align:top"><p>Severe</p></td><td style="vertical-align:top"><p>&lt; 30</p></td><td style="vertical-align:top"><p>5 mg once every 2 days</p></td></tr><tr><td style="vertical-align:top"><p>End-stage renal disease -</p><p>Patients undergoing dialysis</p></td><td style="vertical-align:top"><p>&lt; 10</p></td><td style="vertical-align:top"><p>Contraindicated</p></td></tr></tbody></table><p>In paediatric patients suffering from renal impairment, the dose will have to be adjusted on an individual basis taking into account the renal clearance, age and&nbsp;body weight of the patient.</p><p><strong>Hepatic impairment</strong></p><p>No dose adjustment is needed in patients with solely hepatic impairment.</p><p><strong>Patients with hepatic impairment and renal impairment</strong></p><p>Dose adjustment is recommended&nbsp;(see Renal Impairment above).</p><p><strong>Method of administration:</strong></p><p>The solution can be swallowed as such.</p><p><strong>Route of Administration</strong></p><p>For oral use.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cetirizine is contraindicated in:
•	Hypersensitivity to any of the constituents of this formulation, to hydroxyzine or to any piperazine derivatives.
•	Patients with severe renal impairment at less than 10 ml/min creatinine clearance.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Alcohol</strong></p><p>At therapeutic doses, no clinically significant interactions have been demonstrated with alcohol (for a blood alcohol level of 0.5 g/L).&nbsp; Nevertheless, precaution is recommended if alcohol is taken concomitantly (see Section Interactions).</p><p><strong>Increased risk of urinary retention</strong></p><p>Caution should be taken in patients with predisposition factors of urinary retention (e.g. spinal cord lesion, prostatic hyperplasia) as cetirizine may increase the risk of urinary retention.</p><p><strong>Patients at risk of convulsions</strong></p><p>Caution in epileptic patients and patients at risk of convulsions is recommended.</p><p><strong>Skin reactions</strong></p><p>Pruritus and/or urticaria may occur when cetirizine is stopped, even if those symptoms were not present before treatment initiation. In some cases, the symptoms may be intense and may require treatment to be restarted. The symptoms should resolve when the treatment is restarted.</p><p><strong>Children</strong></p><p>The use of the film-coated tablet formulation is not recommended in children aged less than 6 years since this formulation does not allow for appropriate dose adaptation.</p><p><strong>Allergy skin tests</strong></p><p>Allergy skin tests are inhibited by antihistamines and a wash-out period of 3 days is recommended before performing them.</p><p><strong>Food</strong></p><p>The extent of absorption of cetirizine is not reduced with food, although the rate of absorption is decreased.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Due to the pharmacokinetic, pharmacodynamic and tolerance profile of cetirizine, no interactions are expected with this antihistamine. Neither pharmacodynamic nor significant pharmacokinetic interaction was reported in drug-drug interactions studies performed, notably with pseudoephedrine or theophylline (400 mg/day).</p><p><strong>Alcohol and other CNS depressants</strong></p><p>In sensitive patients, the concurrent use of alcohol or other CNS depressants may cause additional reductions in alertness and impairment of performance, although cetirizine does not potentiate the effect of alcohol (0.5 g/L blood levels) (see Section Warnings and Precautions).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Fertility</strong></p><p>Limited data is available on human fertility but no safety concern has been identified.</p><p>Animal data show no safety concern for human reproduction.</p><p><strong>Pregnancy</strong></p><p>Caution should be exercised when prescribing to pregnant women.</p><p>For cetirizine prospectively collected data on pregnancy outcomes do not suggest potential for maternal or foetal/embryonic toxicity above background rates.</p><p>Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development.&nbsp;</p><p><strong>Lactation</strong></p><p>Caution should be exercised when prescribing cetirizine to lactating women.</p><p>Cetirizine is excreted in human milk at concentrations representing 25%&nbsp;to 90% of those measured in plasma, depending on sampling time after administration.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Objective measurements of driving ability, sleep latency and assembly line performance have not demonstrated any clinically relevant effects at the recommended dose of 10 mg.</p><p>However, patients who experience somnolence should refrain from driving, engaging in potentially hazardous activities or operating machinery.</p><p>Patients intending to drive, engaging in potentially hazardous activities or operating machinery should not exceed the recommended dose and should take their response to the medicinal product into account.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Clinical Trial Data</strong></p><p>Clinical studies have shown that cetirizine at the recommended dosage has minor adverse effects on the CNS, including somnolence, fatigue, dizziness and headache.&nbsp;</p><p>In some cases, paradoxical CNS stimulation has been reported.</p><p>Although cetirizine is a selective antagonist of peripheral H1-receptors and is relatively free of anticholinergic activity, isolated cases of micturition difficulty, eye accommodation disorders and dry mouth have been reported.</p><p>Instances of abnormal hepatic function with elevated hepatic enzymes accompanied by elevated bilirubin have been reported.&nbsp; Mostly this resolves upon discontinuation of the treatment with cetirizine.</p><p>Double blind controlled clinical trials comparing cetirizine to placebo or other antihistamines at the recommended dosage (10 mg daily for cetirizine), of which quantified safety data are available, included more than 3200 subjects exposed to cetirizine.</p><p>From this pooling, the following adverse reactions were reported for cetirizine 10 mg in the placebo-controlled trials at rates of 1.0 % or greater:</p><table border="1" cellspacing="0" cellpadding="0" style="width:0px"><tbody><tr><td style="vertical-align:top"><p><strong>Adverse reactions</strong></p><p><strong>(WHO-ART)</strong></p></td><td style="vertical-align:top"><p><strong>Cetirizine 10mg</strong></p><p><strong>(n= 3260)</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>(n = 3061)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Body as a whole &ndash; general disorders</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>Fatigue</p></td><td style="vertical-align:top"><p>1.63 %</p></td><td style="vertical-align:top"><p>0.95 %</p></td></tr><tr><td style="vertical-align:top"><p><strong>Central and peripheral nervous system disorders </strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>Dizziness</p><p>Headache</p></td><td style="vertical-align:top"><p>1.10 %</p><p>7.42 %</p></td><td style="vertical-align:top"><p>0.98 %</p><p>8.07 %</p></td></tr><tr><td style="vertical-align:top"><p><strong>Gastro-intestinal disorders</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>Abdominal pain</p><p>Dry mouth</p><p>Nausea</p></td><td style="vertical-align:top"><p>0.98 %</p><p>2.09 %</p><p>1.07 %</p></td><td style="vertical-align:top"><p>1.08 %</p><p>0.82 %</p><p>1.14 %</p></td></tr><tr><td style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p></td></tr><tr><td style="vertical-align:top"><p>Somnolence</p></td><td style="vertical-align:top"><p>9.63 %</p></td><td style="vertical-align:top"><p>5.00 %</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Respiratory system disorders</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>Pharyngitis</p></td><td style="vertical-align:top"><p>1.29 %</p></td><td style="vertical-align:top"><p>1.34 %</p></td></tr></tbody></table><p>Although statistically more common than under placebo, somnolence was mild to moderate in the majority of cases. Objective tests as demonstrated by other studies have demonstrated that usual daily activities are unaffected at the recommended daily dose in healthy young volunteers.</p><p><strong>Paediatric population</strong></p><p>Adverse reactions at rates of 1 % or greater in children aged from 6 months to 12 years, included in placebo-controlled clinical trials are:</p><table border="1" cellspacing="0" cellpadding="0" style="width:0px"><tbody><tr><td style="vertical-align:top"><p><strong>Adverse reactions</strong></p><p><strong>(WHO-ART)</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>Cetirizine</strong></p><p><strong>(n=1656)</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>(n =1294)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Gastro-intestinal disorders</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>Diarrhoea</p></td><td colspan="2" style="vertical-align:top"><p>1.0 %</p></td><td style="vertical-align:top"><p>0.6 %</p></td></tr><tr><td style="vertical-align:top"><p><strong>Psychiatric disorders&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>Somnolence</p></td><td colspan="2" style="vertical-align:top"><p>1.8 %</p></td><td style="vertical-align:top"><p>1. 4 %</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Respiratory system disorders</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rhinitis</p></td><td colspan="2" style="vertical-align:top"><p>1.4 %</p></td><td style="vertical-align:top"><p>1.1 %</p></td></tr><tr><td style="vertical-align:top"><p><strong>Body as a whole &ndash; general disorders</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Fatigue</p></td><td colspan="2" style="vertical-align:top"><p>1.0 %</p></td><td style="vertical-align:top"><p>0.3 %</p></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p><strong>Post-marketing experience</strong></p><p>Adverse drug reactions (ADRs) are listed below by MedDRA system organ class and by frequency.</p><p>Frequencies are defined as:</p><p>Very common &ge;1/10</p><p>Common &ge;1/100 to &lt;1/10</p><p>Uncommon &ge;1/1000 to &lt;1/100</p><p>Rare &ge;1/10000 to &lt;1/1000</p><p>Very rare &lt;1/10000</p><p>Not known (cannot be estimated from the available data).</p><p>&nbsp;</p><p><strong>Blood and lymphatic system disorders</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Very rare:</strong> thrombocytopenia.</p><p><strong>Immune system disorders</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Rare:</strong> hypersensitivity.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Very rare</strong>: anaphylactic shock.</p><p><strong>Metabolism and nutrition disorders</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Not known:</strong> increased appetite.</p><p><strong>Psychiatric disorders</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Uncommon:</strong> agitation.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Rare:</strong> aggression, confusion, depression, hallucination, insomnia.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Very rare:</strong> tics.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Not known:</strong> suicidal ideation, nightmare.</p><p><strong>Nervous system disorders</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Uncommon:</strong> paraesthesia.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Rare:</strong> convulsions.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Very rare:</strong> dysgeusia, syncope, tremor, dystonia, dyskinesia.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Not known:</strong> amnesia, memory impairment.</p><p><strong>Eye disorders</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Very rare:</strong> accommodation disorder, blurred vision, oculogyration.</p><p><strong>Ear and labyrinth disorders.</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Not known:</strong> vertigo.</p><p><strong>Cardiac disorders</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Rare:</strong> tachycardia</p><p><strong>Gastro-intestinal disorders</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Uncommon:</strong> diarrhea</p><p><strong>Hepatobiliary disorders</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Rare</strong>:&nbsp;hepatic function abnormal (transaminases increased, blood bilirubin increased, blood alkaline phosphatase increased, gamma-glutamyl transferase increased)</p><p><strong>Skin and subcutaneous tissue disorders</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Uncommon:</strong> pruritus, rash.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Rare:</strong> urticaria.</p><p><strong>Renal and urinary disorders</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Very rare:</strong> dysuria, enuresis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Not known:</strong> urinary retention (See section Warning and precaution).</p><p><strong>General disorders and administration site conditions</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Uncommon:</strong> asthenia, malaise.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Rare:</strong> oedema.</p><p><strong>Investigations</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Rare:</strong> weight increased.</p><p><strong>Skin reactions occurring after discontinuation of cetirizine</strong></p><p>After discontinuation of cetirizine, pruritus (intense itching) and/or urticaria have been reported&nbsp;(see Section Warnings and Precautions).</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p><strong>&bull;Saudi Arabia:</strong></p><p>The National Pharmacovigilance Center (NPC):</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><p><strong>&bull;United Arab of Emirates:</strong></p><p>Pharmacovigilance and Medical Device Section</p><p>P.O. Box: 1853, Tel: 80011111</p><p>Email: pv@mohap.gov.ae</p><p>Drug Department, Ministry of Health &amp; Prevention</p><p>Dubai-UAE.</p><p><strong>&bull;Other GCC States:</strong></p><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Symptoms and signs</strong></p><p>Symptoms observed after an overdose of cetirizine are mainly associated with CNS effects or with effects that could suggest an anticholinergic effect.</p><p>Adverse events reported after an intake of at least 5 times the recommended daily dose are: confusion, diarrhoea, dizziness, fatigue, headache, malaise, mydriasis, pruritus, restlessness, sedation, somnolence, stupor, tachycardia, tremor, and urinary retention.</p><p><strong>Treatment</strong></p><p>There is no known specific antidote to cetirizine.</p><p>Should overdose occur, symptomatic or supportive treatment is recommended.</p><p>Cetirizine is not effectively removed by haemodialysis.</p><p>Management should be as clinically indicated or as recommended by the national poisons centre, where available.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group</strong></p><p>Antihistamines for systemic use, piperazine derivatives, <strong>ATC Code:</strong> R06AE07</p><p><strong>Mechanism of Action and Pharmacodynamic effects</strong></p><p>Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H1-receptors.&nbsp;&nbsp;In vitro&nbsp;receptor binding studies have shown no measurable affinity for receptors other than H1-receptors.</p><p>In addition to its anti-H1&nbsp;effect, cetirizine was shown to display anti-allergic activities: at a dose of 10 mg once or twice daily, it inhibits the late phase recruitment of inflammatory cells, notably eosinophils, in the skin and conjunctiva of atopic subjects submitted to antigen challenge.</p><p>Studies in healthy volunteers show that cetirizine, at doses of 5 and 10 mg strongly inhibits the wheal and flare reactions induced by very high concentrations of histamine into the skin, but the correlation with efficacy is not established. The onset of activity after a single 10 mg dose occurs within 20 minutes in 50 % of the subjects and within one hour in 95 %.&nbsp; This activity persists for at least 24 hours after a single administration.&nbsp;</p><p>In a six-week, placebo-controlled study of 186 patients with allergic rhinitis and concomitant mild to moderate asthma, cetirizine 10 mg once daily improved rhinitis symptoms and did not alter pulmonary function. This study supports the safety of administering cetirizine to allergic patients with mild to moderate asthma.</p><p>In a placebo-controlled study, cetirizine given at the high daily dose of 60 mg for seven days did not cause statistically significant prolongation of QT interval.</p><p>At the recommended dosage, cetirizine has demonstrated that it improves the quality of life of patients with perennial and seasonal allergic rhinitis.</p><p>In a 35-day study in children aged 5 to 12, no tolerance to the antihistaminic effect (suppression of wheal and flare) of cetirizine was found.&nbsp; When a treatment with cetirizine is stopped after repeated administration, the skin recovers its normal reactivity to histamine within 3 days.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong></p><p>The steady - state peak plasma concentrations is approximately 300 ng/ml and is achieved within 1.0 &plusmn; 0.5 h..The distribution of pharmacokinetic parameters such as peak plasma concentration (Cmax) and area under curve (AUC) is unimodal.</p><p>The extent of absorption of cetirizine is not reduced with food, although the rate of absorption is decreased. The extent of bioavailability is similar when cetirizine is given as solutions, capsules or tablets.</p><p><strong>Distribution</strong></p><p>The apparent volume of distribution is 0.50 l/kg. Plasma protein binding of cetirizine is 93 &plusmn; 0.3 %. Cetirizine does not modify the protein binding of warfarin.</p><p><strong>Biotransformation</strong></p><p>Cetirizine does not undergo extensive first pass metabolism.</p><p><strong>Elimination</strong></p><p>The terminal half-life is approximately 10 hours and no accumulation is observed for cetirizine following daily doses of 10 mg for 10 days. About two third of the dose are excreted unchanged in urine.</p><p><strong>Linearity/Non-linearity</strong></p><p>Cetirizine exhibits linear kinetics over the range of 5 to 60 mg.</p><p><strong>Renal impairment:&nbsp;</strong>The pharmacokinetics of the drug was similar in patients with mild impairment (creatinine clearance higher than 40 ml/min) and healthy volunteers. Patients with moderate renal impairment had a 3-fold increase in half-life and 70 % decrease in clearance compared to healthy volunteers.</p><p>Patients on hemodialysis (creatinine clearance less than 7 ml/min) given a single oral 10 mg dose of cetirizine had a 3-fold increase in half-life and a 70 % decrease in clearance compared to normals. Cetirizine was poorly cleared by haemodialysis. Dosing adjustment is necessary in patients with moderate or severe renal impairment (see section 4.2).</p><p><strong>Hepatic impairment:</strong>&nbsp;Patients with chronic liver diseases (hepatocellular, cholestatic, and biliary cirrhosis) given 10 or 20 mg of cetirizine as a single dose had a 50 % increase in half-life along with a 40 % decrease in clearance compared to healthy subjects.</p><p>Dosing adjustment is only necessary in patients with hepatic impairment if concomitant renal impairment is present.</p><p><strong>Elderly:</strong>&nbsp;Following a single 10 mg oral dose, half-life increased by about 50 % and clearance decreased by 40 % in 16 elderly subjects compared to the normal subjects. The decrease in cetirizine clearance in these elderly volunteers appeared to be related to their decreased renal function.</p><p><strong>Pediatric population:</strong>&nbsp;The half-life of cetirizine was about 6 hours in children of 6-12 years and 5 hours in children 2-6 years. In infants and toddlers aged 6 to 24 months, it is reduced to 3.1 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant for this product.</p><p>Non-clinical information</p><p>Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The other ingredients are sorbitol powder, glycerin, propylene glycol, sodium saccharin (fine powder), methyl paraben, banana liquid flavor, trisodium citrate 2H2O.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30. Do not refrigerate.</p><p>After opening, the solution should be used within 20 days.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Finallerg <sup>&reg;</sup>oral solution: </strong>is a clear colorless solution with banana odor, presented in amber glass bottles type III, 100 ml, with white polypropylene child resistant screw cap with low density polyethylene transparent plug and white sealing ring embossed drawing on top explaining how to open the cap, intended for oral use. <strong>Pack size:</strong> 100 ml.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Pharma International Company
Amman - Jordan
Tel: 00962-6-5158890 / 5157893
Fax: 00962-6-5154753
Email: marketing@pic-jo.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                11/2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>